on 18 Aug 2023
Last Applicant/ Owned by
POINT BIOPHARMA USA INC.
4850 West 78th St.Indianapolis IN 46268
US
Serial Number
2183842 filed on 31st Mar 2022
Correspondent Address
FASKEN MARTINEAU DUMOULIN S.E.N.C.R.L., SRL
365, rue Abraham-Martinbureau 600Québec
QUEBEC
CA
G1K8N2
Trademark usage description
pharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncol Read More11
11
2183842
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 48 on 30th Jan 2024 | Agent Changed |
Submitted for opposition 22 on 18th Aug 2023 | Search Recorded |
Submitted for opposition 20 on 18th Aug 2023 | Examiner's First Report |
Submitted for opposition 223 on 18th Aug 2023 | Total Provisional Refusal |
Submitted for opposition 256 on 6th Mar 2023 | Notification of Possible Opposition Sent |
Submitted for opposition 257 on 5th May 2022 | Designation Notification - Madrid Protocol |
Submitted for opposition 31 on 5th May 2022 | Formalized |
Submitted for opposition 1 on 5th May 2022 | Created |
Submitted for opposition 228 on 31st Mar 2022 | International Registration |
Submitted for opposition 30 on 31st Mar 2022 | Filed |